Alfredo Gorio

Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study.

Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.

Bone disease in uremic patients: advances in PTH suppression.

Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone.

Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.

Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

G protein-mediated signal transduction is affected in primary biliary cirrhosis.

Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells.

Up-regulation of focal adhesion kinase in non-small cell lung cancer.

A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia.

Survivin expression in tuberous sclerosis complex cells.

Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord.

Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone.

Acrylate end-capped poly(ester-carbonate) and poly(ether-ester)s for polymer-on-multielectrode array devices: synthesis, photocuring, and biocompatibility.

Viability-dependent promoting action of adult neural precursors in spinal cord injury.

Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM.

The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells.

Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice.

Lymphangioleiomyomatosis and TSC2-/- cells.

Acute spinal cord injury persistently reduces R/G RNA editing of AMPA receptors.

Adult neural precursors isolated from post mortem brain yield mostly neurons: an erythropoietin-dependent process.

Erythropoietin: recent developments in the treatment of spinal cord injury.

Voltage-dependent ionic channels in differentiating neural precursor cells collected from adult mouse brains six hours post-mortem.

Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations.

Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice.

A specific combination of zeaxanthin, spermidine and rutin prevents apoptosis in human dermal papilla cells.

Chromatin remodeling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin.

The use of poly(N-[2-hydroxypropyl]-methacrylamide) hydrogel to repair a T10 spinal cord hemisection in rat: a behavioural, electrophysiological and anatomical examination.

Kainate receptor RNA editing is markedly altered by acute spinal cord injury.

Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations.

Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury.

TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.

Characteristics and Properties of Mesenchymal Stem Cells Derived from Micro-fragmented Adipose Tissue.

Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.